1. Market Research
  2. > Biotechnology
  3. > Medical Biotechnology Market Trends
  4. > Global Medical Biotechnology Analysis & Statistics

Global Medical Biotechnology Analysis & Statistics

Customer Support

Talk to Ahmad

+1 718 618 4302

Publication dates

Publishers

  • All
    • Kelly Scientific Publications

All regions

1-5 of 5 reports

Global Cancer Immunotherapy Market Analysis & Forecast to 2023

  • $ 4900
  • January 2020
  • 450 pages

Within the cancer therapeutics space, which today is worth over $100 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that have ...

  • Medical Biotechnology
  • Therapy
  • World

Global Regenerative Medicine Market Analysis & Forecast to 2023: Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries

  • $ 4900
  • January 2019
  • 700 pages

This report provides a comprehensive overview of the size of the regenerative medicine market, segmentation of the market (stem cells, tissue engineering and CAR-T therapy), key players and the vast potential ...

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • World
  • Forecast

Global Gene Therapy Market Analysis & Forecast to 2022

  • $ 4900
  • March 2018
  • 310 pages

Growing at a CAGR of over x% the global gene therapy market is forecast to hit $363 million by 2022 from $x million in 2017. Strengthened by recent approvals of Kymriah, Yescarta and Luxturna in the US, ...

  • Biopharmaceutical
  • Gene Therapy
  • Medical Biotechnology
  • Pharmaceutical
  • World

GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020

  • $ 3800
  • July 2016
  • 317 pages

This report provides a comprehensive overview of the size of cancer immunotherapy market, the segmentation of the market, key players and the vast potential of therapies that are in clinical trials. Oncologic ...

  • Medical Biotechnology
  • Therapy
  • World

Global & USA BioSimilar Market Analysis to 2021; Product Pipelines, Trends, Key Players, Regulations and Strategic Outlook

  • $ 3400
  • August 2015
  • 271 pages

Biosimilars are highly-similar versions of biological drugs that are indicated for cancer, kidney disorders and a wide range of autoimmune diseases. Originator biologics are the most expensive drugs in ...

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • United States
  • World



Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on